Founded in 2016 by Prof. Moshe Szyf, a global pioneer in the dynamic and rapidly evolving field of epigenetics, EpiMedTech Global (EMTG) stands as a force driving innovation. Headquartered in Singapore, EMTG operates a research and diagnostic lab at the Hong Kong Science Park, which serves as the epicenter of groundbreaking endeavors. Additionally, our innovation and bioinformatics arm, MTL Epitherapeutics, is based in Montreal, Canada. Our dedicated scientists are committed to advancing epigenetics and early disease detection. At EMTG, it’s not just about detecting diseases; it’s about offering solutions that promote longevity through the hidden stories in our DNA.